C3 Jian is a Los Angeles-based biotechnology company focused on improving oral health through the development and commercialization of novel products based on our proprietary cell signaling platform technology. Our innovative technology platform has led to the discovery of lead compounds that selectively diagnose and treat the cause of dental caries (cavities) as well as disorders of mineralization.
The company’s lead therapeutic, Sm STAMPs, specifically targets bacteria responsible for caries infections. We believe this peptide-based pharmaceutical product has the potential to provide long-term benefits by promoting a “healthy plaque” through preservation of the beneficial microflora of the oral cavity.
C3 Jian strives to bring about a future where targeted medicine can more effectively treat infectious disease. Our goal is to bring better medicine to the practice of dentistry.